Arun Raturi

Arun Raturi has extensive work experience in the field of nanoparticle-based platforms for the delivery of nucleic acids, small molecules, and bio-therapeutics for various applications such as cancer therapy, vaccines, and anti-aging. Arun worked at Entos Pharmaceuticals as a CSO, focusing on the in-vivo delivery of non-toxic liposomal formulations of miRNA, mRNA, SiRNA, DNA, and crispr. Arun also held the position of Senior Research Scientist at Entos Pharmaceuticals, where they continued their work on nanoparticle-based platforms. Prior to that, they were a Research Associate at the University of Alberta. Arun Raturi also worked as a Scientist at Intas Biopharmaceuticals, with responsibilities including the development of screening and neutralizing assays for cancer drugs, as well as the development of cell-based assays for drug release. Arun has additional research experience as a Research Associate at The Scripps Research Institute and as a Research Associate at Intas Biopharmaceuticals. Arun'scareer started as a Research Associate at Wockhardt Research Centre, Aurangabad.

Arun Raturi completed their education in a sequential manner. Arun first pursued a Master's degree in Biotechnology at the Indian Institute of Technology, Roorkee, from 1996 to 1998. Following this, they enrolled in the Indian Institute of Technology (Banaras Hindu University), Varanasi, where they obtained a M.Tech in Biochemical Engineering from 1998 to 2000. Subsequently, they pursued a PhD in Biochemistry at the University of Windsor from 2002 to 2007.